[COVID-19: From a clinician's perspective.]

Area of Science:

• Medicine
• Infectious Diseases
• Public Health

Background:

• Coronavirus disease 2019 (COVID-19) is a significant global respiratory tract infection caused by the SARS-CoV-2 virus.
• As of March 30, 2020, over 693,000 cases were reported worldwide, with 1,446 in Japan.
• Dominant transmission routes include contact and droplet inhalation, with potential for airborne spread during aerosol-generating procedures.

Purpose of the Study:

• To provide an overview of COVID-19, including its transmission, clinical presentation, diagnosis, and management.
• To highlight risk factors for severe disease, such as underlying conditions and advanced age.
• To emphasize the importance of preventive measures against contact, droplet, and airborne transmission.

Main Methods:

• Diagnosis relies on detecting SARS-CoV-2 via polymerase chain reaction (PCR) testing.
• Nasopharyngeal swabs or sputum samples are utilized for PCR analysis.
• Review of current understanding of transmission routes and clinical progression.

Main Results:

• COVID-19 presents with upper respiratory tract inflammation, potentially progressing to severe pneumonia.
• Underlying diseases and older age are identified as risk factors for severe outcomes.
• Currently, no specific effective therapeutic agent is available; symptomatic management is standard.

Conclusions:

• Effective prevention strategies are essential, focusing on contact, droplet, and airborne precautions.
• Continued research is needed to identify effective therapeutic agents for COVID-19.
• Public health measures are critical to control the spread of SARS-CoV-2 infection.